Skip to main content
Equibles
BFRG logo

BFRG · BullFrog AI Holdings, Inc. · Metrics

Track BFRG — free

Use BFRG with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research BFRG.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.55 -0.03 (-4.67%) At close · Nov 12
Rebalance outlook locked
Going-concern doubt — flagged Aug 14, 2026

Substantial doubt about the company's ability to continue as a going concern.

“As of June 30, 2026, the Company's cash and cash equivalents position is not sufficient to fund the Company's planned operations for at least a year beyond the filing date of the unaudited condensed consolidated financial statements. This factor as well as other factors raise substantial doubt about the Company's ability to continue as a going concern. The ability to continue as a going concern is dependent upon the Company obtaining the necessary financing or revenues to meet its obligations arising from normal business operations when they become due.”
View the 10-Q filed Aug 14, 2026
Market Cap
$10.25M
Shares
18.54M
Volume · Nov 12 123.31K Avg daily vol (3M) 5.29M

BFRG metrics

69 of 125 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$0.55
Market cap
$10.25M

Price action

23 metrics
Price change (1W)
+10.2%
Price change (30D)
+2.0%
Price change (3M)
+0.0%
Price change (6M)
-7.9%
Price change (YTD)
-34.3%
Price change (1Y)
-46.8%
Trailing year
Price change (5Y)
—
52-week high
$1.68
52-week low
$0.43
Change from 52-week high
-65.5%
Change from 52-week low
+35.2%
Annualized volatility
167.9%
Annualized volatility (3M)
151.3%
Implied volatility (30D)
—
IV rank (1Y)
—
IV percentile (1Y)
—
Beta
2.6
RSI (14D)
55.7
Price vs SMA 50
+5.0%
Price vs SMA 200
-10.1%
Avg volume (3M)
5.29M
Relative volume
0.0
Average dollar volume
$4.31M

Company

3 metrics
Sector
Healthcare
Industry
Health Information Services
Shares outstanding
18.54M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
29.5×
reciprocal yield 3.4%
EV / EBITDA
—
EV / EBIT
—
P / sales
36.0×
reciprocal yield 2.8%
P / book
1.5
reciprocal yield 65.0%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-55.8%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
—

Profitability

9 metrics
Gross margin
40.9%
Operating margin
-5,652.4%
Trailing 12 months
Net margin
-5,569.6%
Gross profit (TTM)
$122,269
Operating profit (TTM)
−$6.10M
Net income (TTM)
−$6.00M
Trailing 12 months
Diluted EPS (TTM)
$-0.46
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$0.19

Growth

11 metrics
Revenue growth YoY
+547.6%
Year over year
Net income growth YoY
—
Revenue (TTM)
$298,798
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+93.8%
Year over year · more shares
Revenue CAGR (3Y)
+126.8%
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-85.8%
Return on assets
-77.9%
Debt / equity
0.0
Current ratio
10.6
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
10.6
Interest coverage
-1,105.4
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$1.94M
Latest balance sheet
Cash & equivalents
$6.92M
Total assets
$7.69M
Total debt
$55,606

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$5.50M
Capital expenditures (TTM)
—
R&D (TTM)
$1.52M
SG&A (TTM)
—
Stock compensation (TTM)
$768,929
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

9 metrics
13F filers
22
13F filer change QoQ
+2
Institutional ownership
7.5%
Conviction holders (share of 13F filers)
0.0%
Crowding (high-turnover and private-fund holders)
2.6%
Private-fund adviser ownership
2.0%
Active holders' share change QoQ
+135.5%
Holder tenure
3.0
Price vs estimated holder cost
-33.5%

Ownership (registered funds)

1 metrics
Index-fund ownership
0.8%

Short interest

3 metrics
Short interest
4.1%
Latest settlement · 4.3 days to cover
Days to cover
4.3d
Short-squeeze score
48 / 100

Insider activity

2 metrics
Net insider buying (90D)
$71,342
Insider-sentiment score
88 / 100

Risk flags

1 metrics
Going concern
Flagged
Key facts CIK 1829247 CUSIP 12021E109 13F (30d) 19 filings 15 filers Visit website Investor relations